Category: Life Sciences
Global Life Sciences
-
Dental Consumables
... CAGR of 6.6% over the analysis period 2024-2030. Dental Restoration, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$15.9 Billion by the end of the analysis ... Read More
-
Analytical Standards
... CAGR of 6.6% over the analysis period 2024-2030. Pharmaceutical & Life Science Analysis Application, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$611.4 Million by the ... Read More
-
Disabled and Elderly Assistive Technology
... Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Communication Aids, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$16.3 Billion ... Read More
-
Continuous Renal Replacement Therapy (CRRT)
... Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Dialysates & Replacement Fluids, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach ... Read More
-
Dental Practice Management Software
... 2030, growing at a CAGR of 9.3% over the analysis period 2024-2030. Web-based, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$1.7 Billion by the end ... Read More
-
Diagnostic Imaging
... CAGR of 5.1% over the analysis period 2024-2030. X-ray Imaging, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$9.4 Billion by the end of the analysis ... Read More
-
Proteomics
... 10.1% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$49.2 Billion by the end of the analysis period. Growth in ... Read More
-
Radio Frequency Identification (RFID) Technology
... Billion by 2030, growing at a CAGR of 14.4% over the analysis period 2024-2030. Tags, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$51.8 Billion by ... Read More
-
Medical Plastics
... CAGR of 6.3% over the analysis period 2024-2030. Engineering Plastics, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$6.3 Billion by the end of the analysis ... Read More
-
Pharmaceutical Contract Manufacturing
... at a CAGR of 5.2% over the analysis period 2024-2030. Pharmaceutical, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$93.8 Billion by the end of the ... Read More
-
Medical Tourism
... CAGR of 13.2% over the analysis period 2024-2030. Cardiovascular, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$47.1 Billion by the end of the analysis period. ... Read More
-
Brachytherapy
... 4.3% over the analysis period 2024-2030. High Dose Rate, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$1.6 Billion by the end of the analysis period. ... Read More
-
Automated and Rapid Microbiological Tests
... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. GC/CRT (Clinical), one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$1.3 Billion ... Read More
-
Connectors
... 5.8% over the analysis period 2024-2030. PCB Connectors, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$34.0 Billion by the end of the analysis period. Growth ... Read More
-
Marine Biotechnology
... CAGR of 8.4% over the analysis period 2024-2030. Biomaterials, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$6.5 Billion by the end of the analysis period. ... Read More
-
Antimicrobial Coatings
... CAGR of 8.1% over the analysis period 2024-2030. Silver, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$8.3 Billion by the end of the analysis period. ... Read More
-
Vitamins
... 6.0% over the analysis period 2024-2030. Vitamin B, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.5 Billion by the end of the analysis period. Growth ... Read More
-
Ibuprofen API
... CAGR of 0.9% over the analysis period 2024-2030. Arthritis Application, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$392.0 Million by the end of the analysis ... Read More
-
Nanobiotechnology
... 7.0% over the analysis period 2024-2030. Pharmaceuticals & Biotechnology Industry, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$122.7 Billion by the end of the analysis ... Read More
-
Carotid Stents
... CAGR of 8.6% over the analysis period 2024-2030. Balloon Expandable Stents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$4.3 Billion by the end of the ... Read More
-
Ventricular Assist Devices
... at a CAGR of 15.6% over the analysis period 2024-2030. Left Ventricular Assist Devices (LVADs), one of the segments analyzed in the report, is expected to record a 15.8% CAGR and reach US$10.6 Billion by ... Read More
-
3D Dental Scanners
... at a CAGR of 10.2% over the analysis period 2024-2030. Desktop / Laboratory Scanners, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$1.2 Billion by the ... Read More
-
Adhesion Barriers
... CAGR of 6.6% over the analysis period 2024-2030. Synthetic Adhesion Barriers, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$825.4 Million by the end of the ... Read More
-
Advanced Authentication
... CAGR of 13.1% over the analysis period 2024-2030. Smart Cards, one of the segments analyzed in the report, is expected to record a 12.1% CAGR and reach US$18.7 Billion by the end of the analysis ... Read More
-
Cancer Supportive Care
... at a CAGR of 2.2% over the analysis period 2024-2030. Opioids, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$11.1 Billion by the end of the ... Read More
Research Assistance
